These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 12433378)

  • 1. Oral tolerance for treating uveitis - new hope for an old immunological mechanism.
    Thurau SR; Wildner G
    Prog Retin Eye Res; 2002 Nov; 21(6):577-89. PubMed ID: 12433378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens.
    Weiner HL; Friedman A; Miller A; Khoury SJ; al-Sabbagh A; Santos L; Sayegh M; Nussenblatt RB; Trentham DE; Hafler DA
    Annu Rev Immunol; 1994; 12():809-37. PubMed ID: 8011298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application of oral tolerance to the treatment of autoimmune diseases--active suppression and bystander suppression].
    Matsui M
    Nihon Rinsho; 1997 Jun; 55(6):1537-42. PubMed ID: 9200945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneously relapsing-remitting experimental autoimmune uveitis in rats allows successful therapeutic oral tolerance induction in ongoing disease.
    Huber A; Diedrichs-Möhring M; Wildner G
    Mol Immunol; 2015 Feb; 63(2):215-26. PubMed ID: 25085538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral tolerance: elucidation of mechanisms and application to treatment of autoimmune diseases.
    Fowler E; Weiner HL
    Biopolymers; 1997; 43(4):323-35. PubMed ID: 9316395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral tolerance with an HLA-peptide mimicking retinal autoantigen as a treatment of autoimmune uveitis.
    Thurau SR; Diedrichs-Möhring M; Fricke H; Burchardi C; Wildner G
    Immunol Lett; 1999 Jun; 68(2-3):205-12. PubMed ID: 10424422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols.
    Gregerson DS; Obritsch WF; Donoso LA
    J Immunol; 1993 Nov; 151(10):5751-61. PubMed ID: 7693817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral tolerance in experimental autoimmune uveoretinitis: feeding after disease induction is less protective than prefeeding.
    Torseth JW; Gregerson DS
    Clin Immunol Immunopathol; 1998 Sep; 88(3):297-304. PubMed ID: 9743617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral tolerance: therapeutic implications for autoimmune diseases.
    Faria AM; Weiner HL
    Clin Dev Immunol; 2006; 13(2-4):143-57. PubMed ID: 17162357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mimicry as a therapeutic approach for an autoimmune disease: oral treatment of uveitis-patients with an MHC-peptide crossreactive with autoantigen--first results.
    Thurau SR; Diedrichs-Möhring M; Fricke H; Arbogast S; Wildner G
    Immunol Lett; 1997 Jun; 57(1-3):193-201. PubMed ID: 9232451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interphotoreceptor retinoid binding protein is a potent tolerogen in Lewis rat: suppression of experimental autoimmune uveoretinitis is retinal antigen specific.
    Laliotou B; Liversidge J; Forrester JV; Dick AD
    Br J Ophthalmol; 1997 Jan; 81(1):61-7. PubMed ID: 9135411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral tolerance in the control of experimental models of autoimmune disease.
    Staines NA; Harper N
    Z Rheumatol; 1995; 54(3):145-54. PubMed ID: 7660685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An HLA-peptide mimics organ-specific antigen in autoimmune uveitis: its role in pathogenesis and therapeutic induction of oral tolerance.
    Thurau SR; Wildner G
    Autoimmun Rev; 2003 Jun; 2(4):171-6. PubMed ID: 12848942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral tolerance.
    Weiner HL; da Cunha AP; Quintana F; Wu H
    Immunol Rev; 2011 May; 241(1):241-59. PubMed ID: 21488901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral tolerance for the treatment of autoimmune diseases.
    Weiner HL
    Annu Rev Med; 1997; 48():341-51. PubMed ID: 9046967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular Components and Mechanisms of Oral Tolerance Induction.
    Rezende RM; Weiner HL
    Crit Rev Immunol; 2018; 38(3):207-231. PubMed ID: 30004858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of autoimmune disease by oral tolerance to autoantigens.
    Whitacre CC; Gienapp IE; Meyer A; Cox KL; Javed N
    Clin Immunol Immunopathol; 1996 Sep; 80(3 Pt 2):S31-9. PubMed ID: 8811061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. History and mechanisms of oral tolerance.
    Rezende RM; Weiner HL
    Semin Immunol; 2017 Apr; 30():3-11. PubMed ID: 28774470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental autoimmune uveitis: molecular mimicry and oral tolerance.
    Singh VK; Nagaraju K
    Immunol Res; 1996; 15(4):323-46. PubMed ID: 8988399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of experimental autoimmune uveitis in Lewis rats by oral administration of recombinant Escherichia coli expressing retinal S-antigen.
    Singh VK; Anand R; Sharma K; Agarwal SS
    Cell Immunol; 1996 Sep; 172(2):158-62. PubMed ID: 8964076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.